Gross cystic disease fluid protein-15/prolactin-inducible protein as a biomarker for keratoconus disease

PLoS ONE

Volumn 9, Issue 11, 2014, Pages

  Priyadarsini, Shrestha ^a   Hjortdal, Jesper ^b   Sarker Nag, Akhee ^a   Sejersen, Henrik ^b   Asara, John M ^c   Karamichos, Dimitrios ^a  

^a UNIVERSITY OF OKLAHOMA HEALTH SCIENCES CENTER   (United States)

^b AARHUS UNIVERSITY HOSPITAL   (Denmark)

^c HARVARD MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ASCORBIC ACID DERIVATIVE; GLYCOPROTEIN; GROSS CYSTIC DISEASE FLUID PROTEIN 15; ISOPROTEIN; SECRETORY PROTEIN; TRANSFORMING GROWTH FACTOR BETA; TRANSFORMING GROWTH FACTOR BETA1; TRANSFORMING GROWTH FACTOR BETA2; TRANSFORMING GROWTH FACTOR BETA3; UNCLASSIFIED DRUG; ZINC ALPHA 2 GLYCOPROTEIN; ASCORBIC ACID; AZGP1 PROTEIN, HUMAN; BIOLOGICAL MARKER; CARRIER PROTEIN; PIP PROTEIN, HUMAN; PROTEOME; VITAMIN;

ADULT; ARTICLE; CELL ISOLATION; CELL STIMULATION; CLINICAL ARTICLE; CONTROLLED STUDY; CORNEA CELL; DISEASE MARKER; DOWN REGULATION; FIBROBLAST; HUMAN; HUMAN CELL; HUMAN TISSUE; IN VITRO STUDY; IN VIVO STUDY; KERATOCONUS; LACRIMAL FLUID; LIQUID CHROMATOGRAPHY; MASS SPECTROMETRY; PROTEIN BINDING; PROTEIN DETERMINATION; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; PROTEOMICS; REAL TIME POLYMERASE CHAIN REACTION; REGULATORY MECHANISM; WESTERN BLOTTING; WOUND HEALING; CELL CULTURE; CORNEA; CYTOLOGY; DRUG EFFECTS; GENE EXPRESSION; GENETICS; METABOLISM; PROCEDURES; TANDEM MASS SPECTROMETRY; YOUNG ADULT;

ADULT; ASCORBIC ACID; BIOMARKERS; BLOTTING, WESTERN; CARRIER PROTEINS; CELLS, CULTURED; CHROMATOGRAPHY, LIQUID; CORNEA; FIBROBLASTS; GENE EXPRESSION; GLYCOPROTEINS; HUMANS; KERATOCONUS; PROTEOME; PROTEOMICS; REAL-TIME POLYMERASE CHAIN REACTION; TANDEM MASS SPECTROMETRY; TRANSFORMING GROWTH FACTOR BETA1; TRANSFORMING GROWTH FACTOR BETA2; TRANSFORMING GROWTH FACTOR BETA3; VITAMINS; YOUNG ADULT;

EID: 84956650972     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0113310     Document Type: Article

References (55)

1. Rabinowitz YS (1998) Keratoconus. Survey of Ophthalmology 42: 297-319.
2. Krachmer JH, Feder RS, Belin MW (1984) Keratoconus and related noninflammatory corneal thinning disorders. Surv Ophthalmol 28: 293-322.
3. Wentz-Hunter K, Cheng EL, Ueda J, Sugar J, Yue BY (2001) Keratocan expression is increased in the stroma of keratoconus corneas. Mol Med 7: 470-477.
4. Romero-Jimenez M, Santodomingo-Rubido J, Wolffsohn JS (2010) Keratoconus: a review. Cont Lens Anterior Eye 33: 157-166; quiz 205.
5. Espandar L, Meyer J (2010) Keratoconus: overview and update on treatment. Middle East Afr J Ophthalmol 17: 15-20.
6. Maguire LJ, Bourne WM (1989) Corneal topography of early keratoconus. Am J Ophthalmol 108: 107-112.
7. Karamichos D, Zareian R, Guo X, Hutcheon AE, Ruberti JW, et al. (2012) Novel Model for Keratoconus Disease. J Funct Biomater 3: 760-775.
8. Sharma M, Boxer Wachler BS (2006) Comparison of single-segment and double-segment Intacs for keratoconus and post-LASIK ectasia. Am J Ophthalmol 141: 891-895.
9. Spoerl E, Huhle M, Seiler T (1998) Induction of cross-links in corneal tissue. Exp Eye Res 66: 97-103.
10. Sporl E, Schreiber J, Hellmund K, Seiler T, Knuschke P (2000) [Studies on the stabilization of the cornea in rabbits]. Ophthalmologe 97: 203-206.
11. Karamichos D, Hutcheon AE, Rich CB, Trinkaus-Randall V, Asara JM, et al. (2014) In vitro model suggests oxidative stress involved in keratoconus disease. Sci Rep 4: 4608.
12. Gallo A, Martini D, Sernissi F, Giacomelli C, Pepe P, et al. (2013) Gross Cystic Disease Fluid Protein-15(GCDFP-15)/Prolactin-Inducible Protein (PIP) as Functional Salivary Biomarker for Primary Sjogren's Syndrome. J Genet Syndr Gene Ther 4.
13. Koo BS, Lee DY, Ha HS, Kim JC, Kim CW (2005) Comparative analysis of the tear protein expression in blepharitis patients using two-dimensional electrophoresis. J Proteome Res 4: 719-724.
14. Karamichos D, Hutcheon AE, Zieske JD (2014) Reversal of fibrosis by TGFbeta3 in a 3D in vitro model. Exp Eye Res.
15. Hassan MI, Kumar V, Singh TP, Yadav S (2008) Purification and characterization of zinc alpha2-glycoprotein-prolactin inducible protein complex from human seminal plasma. J Sep Sci 31: 2318-2324.
16. Hassan MI, Waheed A, Yadav S, Singh TP, Ahmad F (2008) Zinc alpha 2-glycoprotein: a multidisciplinary protein. Mol Cancer Res 6: 892-906.
17. Yuan M, Breitkopf SB, Yang X, Asara JM (2012) A positive/negative ionswitching, targeted mass spectrometry-based metabolomics platform for bodily fluids, cells, and fresh and fixed tissue. Nat Protoc 7: 872-881.
18. Webhofer C, Gormanns P, Reckow S, Lebar M, Maccarrone G, et al. (2013) Proteomic and metabolomic profiling reveals time-dependent changes in hippocampal metabolism upon paroxetine treatment and biomarker candidates. J Psychiatr Res 47: 289-298.
19. Karamichos D, Zareian R, Guo X, Hutcheon AE, Ruberti JW, et al. (2012) Novel in vitro model for keratoconus disease. J Funct Biomater 3: 760-775.
20. Karamichos D, Rich CB, Zareian R, Hutcheon AE, Ruberti JW, et al. (2013) TGF-beta3 stimulates stromal matrix assembly by human corneal keratocyte-like cells. Invest Ophthalmol Vis Sci 54: 6612-6619.
21. Karamichos D, Hutcheon AE, Zieske JD (2011) Transforming growth factorbeta3 regulates assembly of a non-fibrotic matrix in a 3D corneal model. J Tissue Eng Regen Med 5: e228-238.
22. Kim A, Lakshman N, Karamichos D, Petroll WM (2010) Growth factor regulation of corneal keratocyte differentiation and migration in compressed collagen matrices. Invest Ophthalmol Vis Sci 51: 864-875.
23. Karamichos D, Rich CB, Hutcheon AEK, Ren R, Saitta B, et al. (2011) Selfassembled matrix by umbilical cord stem cells. J Funct Biomater 2: 213-229.
24. Chung EH, Hutcheon AE, Joyce NC, Zieske JD (1999) Synchronization of the G1/S transition in response to corneal debridement. Invest Ophthalmol Vis Sci 40: 1952-1958.
25. Albarran C, Pons AM, Lorente A, Montes R, Artigas JM (1997) Influence of the tear film on optical quality of the eye. Cont Lens Anterior Eye 20: 129-135.
26. Fodor M, Kolozsvari BL, Petrovski G, Kettesy BA, Gogolak P, et al. (2013) Effect of contact lens wear on the release of tear mediators in keratoconus. Eye Contact Lens 39: 147-152.
27. Gondhowiardjo TD, van Haeringen NJ, Völker-Dieben HJ, Beekhuis HW, Kok JH, et al. (1993) Analysis of corneal aldehyde dehydrogenase patterns in pathologic corneas. Cornea 12: 146-154.
28. Gondhowiardjo TD, van Haeringen NJ (1993) Corneal aldehyde dehydrogenase, glutathione reductase, and glutathione S-transferase in pathologic corneas. Cornea 12: 310-314.
29. Behndig A, Karlsson K, Johansson BO, Brannstrom T, Marklund SL (2001) Superoxide dismutase isoenzymes in the normal and diseased human cornea. Invest Ophthalmol Vis Sci 42: 2293-2296.
30. Kenney MC, Chwa M, Atilano SR, Tran A, Carballo M, et al. (2005) Increased levels of catalase and cathepsin V/L2 but decreased TIMP-1 in keratoconus corneas: evidence that oxidative stress plays a role in this disorder. Invest Ophthalmol Vis Sci 46: 823-832.
31. Kenney MC, Brown DJ, Rajeev B (2000) Everett Kinsey lecture. The elusive causes of keratoconus: a working hypothesis. CLAO J 26: 10-13.
32. Buddi R, Lin B, Atilano SR, Zorapapel NC, Kenney MC, et al. (2002) Evidence of oxidative stress in human corneal diseases. J Histochem Cytochem 50: 341-351.
33. Udar N, Atilano SR, Small K, Nesburn AB, Kenney MC (2009) SOD1 haplotypes in familial keratoconus. Cornea 28: 902-907.
34. Atilano SR, Coskun P, Chwa M, Jordan N, Reddy V, et al. (2005) Accumulation of mitochondrial DNA damage in keratoconus corneas. Invest Ophthalmol Vis Sci 46: 1256-1263.
35. Daxer A, Fratzl P (1997) Collagen fibril orientation in the human corneal stroma and its implication in keratoconus. Invest Ophthalmol Vis Sci 38: 121-129.
36. Meek KM, Tuft SJ, Huang Y, Gill PS, Hayes S, et al. (2005) Changes in collagen orientation and distribution in keratoconus corneas. Invest Ophthalmol Vis Sci 46: 1948-1956.
37. Radner W, Zehetmayer M, Skorpik C, Mallinger R (1998) Altered organization of collagen in the apex of keratoconus corneas. Ophthalmic Res 30: 327-332.
38. Sawaguchi S, Fukuchi T, Abe H, Kaiya T, Sugar J, et al. (1998) Threedimensional scanning electron microscopic study of keratoconus corneas. Arch Ophthalmol 116: 62-68.
39. Hayes S, Boote C, Tuft SJ, Quantock AJ, Meek KM (2007) A study of corneal thickness, shape and collagen organisation in keratoconus using videokeratography and X-ray scattering techniques. Exp Eye Res 84: 423-434.
40. Mirels L, Hand AR, Branin HJ (1998) Expression of gross cystic disease fluid protein-15/Prolactin-inducible protein in rat salivary glands. J Histochem Cytochem 46: 1061-1071.
41. Autiero M, Cammarota G, Friedlein A, Zulauf M, Chiappetta G, et al. (1995) A 17-kDa CD4-binding glycoprotein present in human seminal plasma and in breast tumor cells. Eur J Immunol 25: 1461-1464.
42. Caputo E, Camarca A, Moharram R, Tornatore P, Thatcher B, et al. (2003) Structural study of GCDFP-15/gp17 in disease versus physiological conditions using a proteomic approach. Biochemistry 42: 6169-6178.
43. Hassan MI, Bilgrami S, Kumar V, Singh N, Yadav S, et al. (2008) Crystal structure of the novel complex formed between zinc alpha2-glycoprotein (ZAG) and prolactin-inducible protein (PIP) from human seminal plasma. J Mol Biol 384: 663-672.
44. Murphy LC, Tsuyuki D, Myal Y, Shiu RP (1987) Isolation and sequencing of a cDNA clone for a prolactin-inducible protein (PIP). Regulation of PIP gene expression in the human breast cancer cell line, T-47D. J Biol Chem 262: 15236-15241.
45. Ueyama H, Niwa M, Tada T, Sasaki M, Ohkubo I (1991) Cloning and nucleotide sequence of a human Zn-alpha 2-glycoprotein cDNA and chromosomal assignment of its gene. Biochem Biophys Res Commun 177: 696-703.
46. Ueyama H, Naitoh H, Ohkubo I (1994) Structure and expression of rat and mouse mRNAs for Zn-alpha 2-glycoprotein. J Biochem 116: 677-681.
47. Karamichos D, Guo XQ, Hutcheon AE, Zieske JD (2010) Human corneal fibrosis: an in vitro model. Invest Ophthalmol Vis Sci 51: 1382-1388.
48. Karamichos D, Lakshman N, Petroll WM (2007) Regulation of corneal fibroblast morphology and collagen reorganization by extracellular matrix mechanical properties. Invest Ophthalmol Vis Sci 48: 5030-5037.
49. Karamichos D, Lakshman N, Petroll WM (2009) An experimental model for assessing fibroblast migration in 3-D collagen matrices. Cell Motil Cytoskeleton 66: 1-9.
50. Haagensen DE, Jr., Dilley WG, Mazoujian G, Wells SA, Jr. (1990) Review of GCDFP-15. An apocrine marker protein. Ann N Y Acad Sci 586: 161-173.
51. Cabassi A, Tedeschi S (2013) Zinc-alpha2-glycoprotein as a marker of fat catabolism in humans. Curr Opin Clin Nutr Metab Care 16: 267-271.
52. Parris TZ, Kovacs A, Aziz L, Hajizadeh S, Nemes S, et al. (2014) Additive effect of the AZGP1, PIP, S100A8 and UBE2C molecular biomarkers improves outcome prediction in breast carcinoma. Int J Cancer 134: 1617-1629.
53. Mui AL, Wakao H, Kinoshita T, Kitamura T, Miyajima A (1996) Suppression of interleukin-3-induced gene expression by a C-terminal truncated Stat5: role of Stat5 in proliferation. EMBO J 15: 2425-2433.
54. Levy DE, Gilliland DG (2000) Divergent roles of STAT1 and STAT5 in malignancy as revealed by gene disruptions in mice. Oncogene 19: 2505-2510.
55. Brizzi MF, Dentelli P, Gambino R, Cabodi S, Cassader M, et al. (2002) STAT5 activation induced by diabetic LDL depends on LDL glycation and occurs via src kinase activity. Diabetes 51: 3311-3317.